BioNTech and its partner Pfizer have stated that investigation suggests that their COVID-19 vaccine can tolerate warmer temperatures than previously believed.

The companies mentioned that they have requested the US Food and Drug Administration to allow that the vaccine be stored for up to two weeks at -25 to -15 degrees Celsius, i.e., -13 to 5 degrees Fahrenheit. These are the common temperatures in pharmaceutical freezers and refrigerators. The existing guidelines suggest that the vaccine needs to be stored at -80 to -60° C until five days prior to use. Pfizer CEO Albert Bourla said that if approval is granted, the new storage option would enable pharmacies and vaccination centers better manage the vaccine supply… (NDTV - Agence France-Presse, February 19, 2021)